New research suggests the hormone kisspeptin shows promise as a potential new treatment for infertility. Scientists led by Dr Waljit Dhillo from Imperial College London, have shown that giving kisspeptin to women with infertility can activate the release of sex hormones which control the menstrual cycle.
This research could lead to a new fertility therapy for women with low sex hormone levels.
Kisspeptin is a product of the KISS-1 gene and is a key regulator of reproductive function. Animals and humans lacking kisspeptin function do not go through puberty and remain sexually immature. In a previous study, Dr Waljit Dhillo and colleagues showed that kisspeptin treatment leads to the production of sex hormones in fertile women; they have now extended their research to look at the effects of kisspeptin in women whose periods have stopped due to a hormone imbalance.
Tags : fertility hormones
Categories : Fertility Drugs
RSS feed for comments on this post
No Response